Biblio

Filters: Author is Pang, Ai-Ming [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Yan F-H, Wang M, Huang Y, Jiang E-L, Ma Q-L, Wei J-L, Pang A-M, Zhang R-L, Feng S-Z, Han M-Z. [Analyses of risk factors for intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2013;34(12):1020-3.

C

Cao Y-G, He Y, Zhang S-D, Liu Z-X, Zhai W-H, Ma Q-L, Pang A-M, Wei J-L, Yang D-L, Huang Y, et al. Conditioning regimen of 5-day decitabine administration for allogeneic stem cell transplantation in patients with myelodysplastic syndrome and myeloproliterative neoplasms. Biol Blood Marrow Transplant. 2019.

E

Hu Y-H, Zhou P-F, Long G-F, Tian X, Guo Y-F, Pang A-M, Di R, Shen Y-N, De Liu Y-, Cui Y-J. Elevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with Thrombocytopenia. Med Sci Monit. 2015;21:3690-3695.

S

Xia Z-Y, Luo C, Liu B-W, Bian X-Q, Li Y, Pang A-M, Xu Y-H, Tan H-M, Zhao Y-H. Shengui Sansheng Pulvis maintains blood-brain barrier integrity by vasoactive intestinal peptide after ischemic stroke. Phytomedicine. 2019;67:153158.